NOV 17, 2022 8:00 AM PST

Medical Cannabis Patients Feel Validated by Changes in Cannabis Stigma and Policy

WRITTEN BY: Kerry Charron

Drexel University researchers examined the effects of California’s 2016 recreational cannabis use law among young adult medical cannabis patients (MCP) and non-patient users (NPU). The study found that increasing acceptance of cannabis and lower patient prices are key reasons why many participants remained MCP. The results were published in the Journal of Drug Issues. 

A total of 30 young adult cannabis users participated in the Drexel study. They were qualitatively interviewed in Los Angeles between 2020-21. The participants were categorized into three groups: 3 MCP who always had a medical cannabis recommendation, 6 NPU who never had a recommendation, and 21 MCP-to-NPU who previously had medical recommendations but changed to non-patient user status after recreational use legalization.

Of the participants classified as MCP-to-NPU and NPU, many remained NPU due to destigmatization of cannabis use and increased legal security. Some participants reported less need for a medical cannabis recommendation after recreational use legalization. Some costs such as recreational cannabis product price increases, the obstacles of finding a physician and the related medical cannabis application and annual fees resulted in some participants seeking less expensive cannabis from unregulated legacy-market dispensaries. 

Drexel University’s Medical Cannabis Research Center has identified key areas for future research on destigmatization, cannabis use, and policy changes. Research focusing on the stigma that cannabis users face after legalization would shed light on factors impacting cannabis access and use. Research on cannabis consumer behavior and attitudes will shed light on why MCPS and NPUs seek out illegal-market alternatives is critical. There is limited research comparing product quality of medical cannabis, recreational cannabis, and black-market sources. Research addressing these topics will help reduce negative unintended outcomes such as MCPs purchasing low quality or contaminated cannabis products from unregulated markets. 

Sources: Drexel University, Journal of Drug Issues 

 

About the Author
BA and MA in English, MPS in Human Relations, and Ed.D. in Higher Education Administration
Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
JUL 28, 2022
Cannabis Sciences
Are Cannabis Users Nicer?
JUL 28, 2022
Are Cannabis Users Nicer?
A study published in Nature offers evidence that cannabis has a positive effect on the psychosocial health of young adul ...
SEP 23, 2022
Cannabis Sciences
Cannabis Legalization's Impact on Pharmaceutical Stock Market Values
SEP 23, 2022
Cannabis Legalization's Impact on Pharmaceutical Stock Market Values
In states with legal medical cannabis, people are curious about using cannabinoid treatment as an alternative to pharmac ...
NOV 01, 2022
Cannabis Sciences
A Tale of Two THCs
NOV 01, 2022
A Tale of Two THCs
University of Connecticut researchers examined the differences between two closely related cannabinoids from the cannabi ...
NOV 17, 2022
Cannabis Sciences
Most Common Side Effects from Consuming Too Much Weed
NOV 17, 2022
Most Common Side Effects from Consuming Too Much Weed
What happens when you ingest too much THC? Whether you smoke, vape, or consume edibles, here's what to expect
NOV 23, 2022
Cannabis Sciences
Why researchers have hope that cannabis may help fight ovarian cancer
NOV 23, 2022
Why researchers have hope that cannabis may help fight ovarian cancer
There's a positive, growing link between cannabis and the fight against ovarian cancer. Here's why researchers are optim ...
DEC 02, 2022
Cancer
No Evidence that Cannabis Relieves Symptoms in Advanced Cancer Patients
DEC 02, 2022
No Evidence that Cannabis Relieves Symptoms in Advanced Cancer Patients
Palliative care describes a class of healthcare intended to enhance patients' quality of life with severe, life-thre ...
Loading Comments...